-
公开(公告)号:US20080287434A1
公开(公告)日:2008-11-20
申请号:US12050969
申请日:2008-03-19
申请人: Agnes PAPPNE BEHR , Zoltan KAPUI , Peter ARANYI , Sandor BATORI , Veronika BARTANE BODOR , Lajos T. NAGY , Mihalyne T. Santa , Marton VARGA , Gyorgy FERENCZY , Endre MIKUS , Katalin URBAN-SZABO , Judit VARGANE SZEREDI , Erzsebet WALCZ , Edit SUSAN
发明人: Agnes PAPPNE BEHR , Zoltan KAPUI , Peter ARANYI , Sandor BATORI , Veronika BARTANE BODOR , Lajos T. NAGY , Mihalyne T. Santa , Marton VARGA , Gyorgy FERENCZY , Endre MIKUS , Katalin URBAN-SZABO , Judit VARGANE SZEREDI , Erzsebet WALCZ , Edit SUSAN
IPC分类号: A61K31/5377 , A61K31/166 , C07C233/78 , A61K31/50 , C07D237/14 , A61P31/18 , A61K31/437 , C07D471/04 , C07D513/04
CPC分类号: C07C233/40 , C07D209/50 , C07D217/24 , C07D235/16 , C07D237/14 , C07D241/44 , C07D263/56 , C07D277/64 , C07D471/04 , C07D513/04
摘要: The invention relates to a compound of the general formula (I), as defined herein which is useful for the treatment of a pathology in a patient wherein a CCR3 receptor plays a role in the development of the pathology, and pharmaceutical preparations containing such compound.The invention is also directed to a process for preparing the compound of the general formula (I), and intermediate useful in the preparation.